Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Fujifilm Licenses Influenza Drug Ingredient to China Drugmaker

By Kyodo News International | June 23, 2016

Fujifilm Corp. said Wednesday it has reached a patent license agreement for an effective ingredient in its anti-influenza drug Avigan Tablet with Chinese pharmaceutical company Zhejiang Hisun Pharmaceutical Co.

It is the first time that Fujifilm has signed a licensing deal with a foreign company for the drug created by its group firm Toyama Chemical Co. that is seen as potentially effective in treating Ebola patients.

Under the deal, Zhejiang Hisun Pharmaceutical will be eligible to use patents related to Favipiravir, an effective ingredient in Avigan, to develop, produce and market an anti-influenza drug in China. Fujifilm will receive a lump-sum payment and royalties once such adrug is successfully introduced into the market.

Human infection with avian influenza has been reported in China. Fujifilm sees an increasing need to develop new drugs for treating influenza amid concern that avian influenza viruses could mutate into a new type of virus capable of human-to-human transmission, the Japanese company said.

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news! 

Related Articles Read More >

Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE